Advances in Understanding the Immunological Pathways in Psoriasis.

Area of Science:

• Immunology
• Dermatology
• Genetics

Background:

• Psoriasis vulgaris is a chronic, immune-mediated skin disorder affecting 2% of the population.
• It significantly impacts patients' quality of life, causing psychological distress.
• Despite extensive research, its exact pathogenesis remains incompletely understood.

Purpose of the Study:

• To review recent advancements in understanding the immunological pathways involved in psoriasis vulgaris pathogenesis.
• To highlight the roles of specific cytokines and immune cells in disease development.

Main Methods:

• Literature review of recent immunological research on psoriasis vulgaris.
• Analysis of the roles of key molecular and cellular players in psoriatic plaque formation.

Main Results:

• Evidence supports the involvement of interleukin (IL)-23, IL-17, IL-22, T helper (Th)-17 cells, Th-22 cells, T regulatory cells, transforming growth factor (TGF)-β1, and IL-10.
• Complex interactions between keratinocytes, dendritic cells, T-lymphocytes, neutrophils, and mast cells contribute to histopathological changes.
• Several inflammatory and anti-inflammatory molecules are under investigation for therapeutic potential.

Conclusions:

• The understanding of psoriasis pathogenesis has evolved, emphasizing the intricate interplay of immune cells and cytokines.
• Targeting specific immunological pathways shows promise for future psoriasis treatments.